Evidence map›Paper›PMID 36334399›Full record

ArticleThrombosis research2022

The homophilic CD84 receptor is upregulated on platelets in COVID-19 and sepsis.

Lukas J Weiss, Maria Drayss, Kristina Mott, Margret Droste, Bastian Just, Anna M Arold, Bernhard Nieswandt, Dirk Weismann, David Stegner, Harald Schulze

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Thrombosis research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Lukas J WeissInstitute of Experimental Biomedicine, University Hospital Würzburg, Germany; Department of Internal Medicine I, University Hospital Würzburg, Germany.
Maria DrayssInstitute of Experimental Biomedicine, University Hospital Würzburg, Germany; Department of Internal Medicine I, University Hospital Würzburg, Germany.
Kristina MottInstitute of Experimental Biomedicine, University Hospital Würzburg, Germany.
Margret DrosteInstitute of Experimental Biomedicine, University Hospital Würzburg, Germany.
Bastian JustInstitute of Experimental Biomedicine, University Hospital Würzburg, Germany.
Anna M AroldInstitute of Experimental Biomedicine, University Hospital Würzburg, Germany.
Bernhard NieswandtInstitute of Experimental Biomedicine, University Hospital Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, Germany.
Dirk WeismannDepartment of Internal Medicine I, University Hospital Würzburg, Germany.
David StegnerInstitute of Experimental Biomedicine, University Hospital Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, Germany.
Harald SchulzeInstitute of Experimental Biomedicine, University Hospital Würzburg, Germany. Electronic address: harald.schulze@uni-wuerzburg.de.
Universitätsklinikum Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SepsisBlood PlateletsHumansSignaling Lymphocytic Activation Molecule FamilyCD84 protein, humanSignaling Lymphocytic Activation Molecule FamilyCD84COVID-19PlateletsSepsisThrombo-inflammation

Identifiers

PMID36334399
PMCPMC9595407
OpenAlexW4307123731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.